|
Market Closed -
London S.E.
03:35:16 14/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 0.5750 GBX | 0.00% |
|
0.00% | +9.52% |
| 12/11 | EARNINGS AND TRADING: Cavendish cuts dividend; Guardian spin-out | AN |
| 11/11 | Thalia Therapeutics Wraps Up In Vitro Study for Lipisiran Cardiovascular Program | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| THALIA THERAPEUTICS PLC | Bio Therapeutic Drugs | 0.00% | 0.00% | +9.52% | -8.00% | -92.33% | 13.5M |  | |  |
- Stock Market
- Stocks
- THAT Stock
- Charts Thalia Therapeutics Plc
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
